Lactate (mmol/L) | Events/no. at risk (%) | Crude HR (95% CI) | Adjusted HR (95% CI)a | RERI (95% CI)b | |||
---|---|---|---|---|---|---|---|
Metformin nonusers | Metformin users | Metformin nonusers | Metformin users | Metformin nonusers | Metformin users | ||
< 1.4 | 1784/13,525 (13%) | 136/1047 (13%) | Reference | 0.98 (0.82 to 1.16) | Reference | 0.95 (0.80 to 1.14) |  |
1.4 to 2.0 | 1400/7947 (18%) | 114/758 (15%) | 1.37 (1.28 to 1.47) | 1.15 (0.95 to 1.39) | 1.45 (1.35 to 1.55) | 1.15 (0.94 to 1.39) | − 0.25 (− 0.54 to 0.03) |
2.0 to 3.2 | 1422/6235 (23%) | 116/596 (19%) | 1.84 (1.72 to 1.97) | 1.53 (1.27 to 1.85) | 2.00 (1.87 to 2.15) | 1.53 (1.26 to 1.86) | − 0.42 (− 0.77 to − 0.07) |
3.2 to 5.0 | 1082/3341 (32%) | 84/353 (24%) | 2.80 (2.60 to 3.02) | 1.90 (1.53 to 2.36) | 2.99 (2.77 to 3.22) | 1.86 (1.49 to 2.33) | − 1.08 (− 1.55 to − 0.60) |
5.0 to 10.0 | 964/2244 (43%) | 105/300 (35%) | 4.17 (3.86 to 4.51) | 3.16 (2.59 to 3.84) | 4.58 (4.24 to 4.96) | 3.10 (2.54 to 3.80) | − 1.43 (− 2.13 to − 0.74) |
≥ 10.0 | 498/818 (61%) | 63/129 (49%) | 7.60 (6.88 to 8.39) | 5.20 (4.04 to 6.69) | 9.24 (8.35 to 10.21) | 5.51 (4.27 to 7.12) | − 3.68 (− 5.30 to − 2.05) |